Filter
353
Text search:
interferon
Featured
Recommendations
54
New Publications
73
Language
Document type
No document type
220
Guidelines
55
Studies & Reports
30
Manuals
24
Fact sheets
9
Strategic & Response Plan
6
Brochures
2
Resource Platforms
2
Infographics
2
Training Material
1
Situation Updates
1
Countries / Regions
Germany
19
Western and Central Europe
19
India
13
Brazil
10
South Africa
7
Russia
5
Paraguay
4
Eastern Europe
4
Nigeria
3
Ethiopia
3
Ghana
3
Philippines
3
Kenya
3
Mozambique
3
Bolivia
3
Myanmar / Burma
3
Latin America and the Carribbean
3
Albania
3
Global
3
Uganda
2
Zambia
2
China
2
Indonesia
2
Bangladesh
2
Argentina
2
Ukraine
2
South–East Asia Region
2
Spain
2
USA
1
Pakistan
1
South Sudan
1
Syria
1
Tanzania
1
Cambodia
1
Malawi
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Switzerland
1
Colombia
1
Botswana
1
Angola
1
Lesotho
1
East and Southern Africa
1
Asia
1
Africa
1
Estonia
1
Romania
1
Georgia
1
North America
1
France
1
Authors & Publishers
Publication Years
Category
Countries
80
Clinical Guidelines
69
Pharmacy & Technologies
10
Public Health
9
Women & Child Health
3
Key Resources
3
Capacity Building
1
Toolboxes
TB
138
HIV
42
COVID-19
35
Refugee
18
NTDs
12
Ebola & Marburg
11
Polio
7
Mental Health
7
Planetary Health
3
Pharmacy
3
Rapid Response
2
Specific Hazards
2
Global Health Education
2
Caregiver
2
NCDs
2
Cholera
1
Conflict
1
Zika
1
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with
...
El agente etiológico de la tuberculosis es el Mycobacterium tuberculosis o bacilo de Koch. Se trata de un bacilo aerobio estricto, ácido-alcohol resistente, sin movilidad, de crecimiento lento y que se inactiva con rayos ultravioleta y temperaturas mayores de 60°C.
The purpose of this guide is to provide updated clinical guidance on TB/HIV, with an emphasis on diagnostic aspects—including new techniques—as well as current treatment, while maintaining a public health approach. By compiling and consolidating the latest World Health Organization recommendatio
...
Tuberculosis (TB) remains a significant global health challenge, with an estimated annual death rate of approximately one per 100,000 people in countries with low TB prevalence. Rapid reductions in TB cases and deaths worldwide depend on research breakthroughs, including the development of new vac
...
WHO consolidated guidelines on tuberculosis: Module 6: tuberculosis and comorbidities, 2nd ed
recommended
Addressing TB comorbidities and risk factors is central to the World Health Organization (WHO) End TB Strategy. These guidelines consolidate the latest WHO recommendations on TB and key comorbidities. The guidelines are a living document and will include dedicated sections for each key TB comorbidit
...
This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It sets out the working group’s shared vision for equitable access to novel TB vaccines and will advance a shared understanding of the current lands
...
A practical toolkot
Guidelines for the Prevention and Treatment of Opportunistic Infections in Children With and Exposed to HIV. Dosing Charts
recommended
New
Dosing Recommendations for Prevention and Treatment
Archives of Medicine vo.7 no.5:10
Individuals infected with human immunodeficiency virus (HIV) often develop
multiple complications and comorbidities, among them, opportunistic infections.
The highest incidence of opportunistic infections was reported in the group
of patients with CD4 lymphocyte
...
